Читать книгу The Fundamentals of Clinical Research - P. Michael Dubinsky - Страница 45

Once a firm has decided to pursue a drug development process it enters a regulated environment which includes GLP, GCP, and cGMP. The plans, actions, and decisions associated with the firm’s drug development initiative must be in tune with and guided by these regulatory requirements. GCP is a part of the regulatory scheme not the entire regulatory scheme.